Northwestern Medicine scientists have demonstrated an important role for the methylation of the amino terminus of a specific protein in maintaining centromere function and chromosome segregation, both important in cell division.
OncoSET, the flagship clinical and research program of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, combines oncology with genomic sequencing to provide cutting-edge cancer care personalized for each patient.
Jack Szostak, PhD, Nobel Laureate and professor of Genetics at Harvard Medical School, spoke on the chemistry of nonezymatic RNA replication at Northwestern’s Chicago campus, the first of the two-part SQI Distinguished Lecture series.
A JAMA study has found that hemoglobin A1C measurements — a biomarker frequently used to diagnose diabetes — may be less accurate in African-Americans with sickle cell trait.
A Northwestern Medicine study has established a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for cardiotoxicity.
A paper published in Molecular Cell provides new insight into a protein complex called COMPASS and its function during histone methylation, a key modification that regulates gene expression.
A new strategy for targeting a protein called GRP78 could be used to simultaneously provide diagnostic imaging and deliver treatment for inflammatory breast cancer, according to a recent study.
Northwestern Medicine scientists have received a $7.5 million grant to study how genetic information from African American patients can predict their responses to medications.
When it comes to gene regulation, there are more similarities between fruit flies and humans than previously thought, according to new Northwestern Medicine research.
Identifying mutations in the estrogen receptor (ER) gene can help clinicians choose effective therapies for patients with ER-positive metastatic breast cancer, according to recent research.